Sidebars: Nov 1, 2010 (Vol. 30, No. 19)

GEN “Cell Counting” Cryptogram Solved

(Page 1 of 1)

    Donna Marie Noga
    Click To Enlarge +

    Donna Marie Noga

    Genetic Engineering & Biotechnology News (GEN), Scintellix, and Bio-Rad Laboratories are delighted to announce that the GEN Cryptogram Challenge: Cell Counting has been solved.

    Donna Marie Noga, a sales administrative assistant at Amresco, cracked the code in spite of the misleading clue 12, which stated that there were more than 22 letters in the answer. Ironically, Donna told GEN that once she saw clue 12 “a light turned on” in her mind and she was able to come up with the correct 22-letter answer to the puzzle on her own: “Count with high precision.”

    For solving the cryptogram Donna won $1,500 and a Bio-Rad VersaFluor™ fluorometer for the Amresco laboratory.

    Donna describes herself as a kind of word sleuth.

    “I have always been intrigued by puzzles and I am very good at word jumble games,” she told GEN. “Over the first eight to ten weeks of the cryptogram contest I was totally baffled. But the last clue gave me an idea of what all the final letters would turn out to be.”

    The GEN Cryptogram Challenge: Cell Counting follows six previous online, cipher-based contests—the MicroArray Challenge and five Cryptogram Challenges (Elisa, Elisa Redux, RNAi, RNAi-2, and Electroporation)—that have each enjoyed great success since 2008.

    Peter Johnson, M.D., president and CEO of Scintellix, and vp of R&D at Avery Dennison Medical, is the creator of all the cryptograms in the GEN Challenge series.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll